arXiv (All)
open access
TrialAtlas: Multi-Agent Research Organization for Clinical Trial Design and Optimization
Nearly 90% of drugs entering clinical development ultimately fail, despite billions of dollars in investment. Pharmaceutical companies therefore rely on clinical development planning (CDP) and probability of technical and regulatory success assessment to anticipate development risks, yet these decis
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Shaping the future of clinical trials through strategic foresight.#269478
- Remote And Decentralised Innovative Approaches to Clinical Trials (RADIAL)#146340
- OPTIMISE-ing consent in clinical trials: recommendations for designing accessible consent processes to address communication and decision-making needs as a barrier to participation#433222
- DÉCISION+, a Continuous Professional Development Program to Improve Optimal Drug Prescription : a Feasibility Study#1151511
- Uncertainty and novel clinical trial designs in oncology - when should equipoise matter?#1158604
Record · ID 1036248
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive